Viewing Study NCT05284812


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-03-02 @ 8:18 AM
Study NCT ID: NCT05284812
Status: SUSPENDED
Last Update Posted: 2023-11-28
First Post: 2022-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module